UKHSA In silico modelling of the Nucleocapsid protein of SARS-CoV-2
Market Engagement for in silico analysis of the impact of mutations of the Nucleocapsid protein of SARS-CoV-2 on lateral flow device sensitivity.
Buyer
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Value
£400,000
Published
27 Sept 2022
Closes
27 Sept 2022
Procurement details
Source
Find a Tender
Region
Tower Hamlets
Procurement method
Not provided
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot 1 UKHSA In silico modelling of the Nucleocapsid protein of SARS-CoV-2
Value not provided
Market Engagement - In silico analysis of the impact of mutations of the Nucleocapsid protein of SARS-CoV-2 on lateral flow device sensitivity. Atamis project reference: C103586<br/><br/>The UK Health Security Agency (UKHSA) wishes to inform the market of a potential future procurement to source a suitably qualified supplier (or an optimal combination of sup...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.